Finance

Lists
007575:KRX
Ilyang Pharmaceutical Co Ltd Preference Shares
7 480,00 KRW
-0,27%
(-20,00) 1D
19-окт., 15:30:00 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 007575...
Open
7 480 KRW
High
7 480 KRW
Low
7 480 KRW
Mkt. cap
142,86 млд
Avg. vol.
426,00
Volume
11,00
Dividend
2,07%
Quarterly dividend
39 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
7,57
52-wk high
15 260 KRW
52-wk low
6 350 KRW
EPS
988 KRW
Shares outstanding
445,08 миң
No. of employees
660
Open
7 480 KRW
High
7 480 KRW
Low
7 480 KRW
Mkt. cap
142,86 млд
Avg. vol.
426,00
Volume
11,00
Dividend
2,07%
Quarterly dividend
39 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
7,57
52-wk high
15 260 KRW
52-wk low
6 350 KRW
EPS
988 KRW
Shares outstanding
445,08 миң
No. of employees
660
News stories
From web sources and news partners
About Ilyang Pharmaceutical Co Ltd Preference Shares
CEOKim Dong-yeon
Employees660
Founded1946-ж., 1-июл.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
68,83 млд
78,91 млд
65,07 млд
65,14 млд
Cost of goods sold
41,32 млд
45,42 млд
40,63 млд
40,74 млд
Cost of revenue
41,32 млд
45,42 млд
40,63 млд
40,74 млд
Research and development expenses
7,01 млд
7,00 млд
8,87 млд
5,94 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,76 млд
24,92 млд
22,29 млд
22,34 млд
Operating expense
27,66 млд
32,93 млд
31,82 млд
31,17 млд
Total operating expenses
68,98 млд
78,35 млд
72,44 млд
71,91 млд
Operating income
-157,75 млн
565,93 млн
-7,37 млд
-6,77 млд
Other non operating income
11,87 млд
-681,30 млн
24,70 млд
2,24 млд
EBT including unusual items
11,42 млд
-1,72 млд
17,95 млд
-5,08 млд
EBT excluding unusual items
11,35 млд
-1,72 млд
17,62 млд
-5,06 млд
Income tax expense
3,04 млд
3,92 млд
983,97 млн
-2,74 млд
Effective tax rate
26,58%
-227,04%
5,48%
53,89%
Other operating expenses
639,84 млн
573,32 млн
453,35 млн
433,71 млн
Net income
8,44 млд
-5,65 млд
16,80 млд
-2,29 млд
Net profit margin
12,26%
-7,16%
25,81%
-3,52%
Earnings per share
-
-
-
-
Interest and investment income
-
184,97 млн
140,72 млн
144,16 млн
Interest expense
-
-738,07 млн
-711,18 млн
-702,63 млн
Net interest expenses
-
-553,10 млн
-570,46 млн
-558,47 млн
Depreciation and amortization charges
212,18 млн
210,49 млн
211,82 млн
220,64 млн
EBITDA
1,93 млд
2,65 млд
-5,30 млд
-4,54 млд
Gain or loss from assets sale
-71,72 млн
6,86 миң
-
31,87 млн
AI content may include mistakes. Learn more
Google колдонмолору